Bristol-Myers Squibb Company: Wells Fargo cuts target price to $60 from $65
BMY•Wells Fargo cut its price target for Bristol-Myers Squibb Company to $60 from $65.
Related News
Alpha Compute Chairman, President Fiorenzo Villani buys $19,570 in common shares
ALP•
Palvella Therapeutics management to join Chardan Healthcare Conference fireside chat
PVLA•
Centene to launch nationwide gold card program for qualifying providers
CNC•
UK's Entain rises after BetMGM posts higher third-quarter revenue
MGM•
NCR Voyix Corporation: Goldman Sachs cuts target price to $8 from $9.75
VYX•